| Model Number |
103695 |
| Medical Device Problem Code |
Mechanical Problem (1384)
|
| Health Effect - Clinical Code |
Thrombosis/Thrombus (4440)
|
| Date of Event |
10/04/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that log files were sent for evaluation due to concern for pump thrombus.The data that was reviewed did not contain attributes which would lead to suspect the presence of thrombus within the motor chamber; however, that does not mean that thrombus was not present in the circulatory loop.It was recommended to look at other clinical indications that may confirm the presence of thrombus.
|
| |
|
Additional Manufacturer Narrative
|
|
No further information provided.A supplemental report will be submitted once the manufacturer investigation is complete.
|
| |
|
Additional Manufacturer Narrative
|
|
Manufacturer's investigation conclusion: the report of suspected pump thrombus could not be confirmed through this evaluation.The submitted log file contained events and data from day 976 through day 983.No notable alarms or events, or significant fluctuations in pump parameters were captured.The pump appeared to function as intended and operated at or above the low-speed limit for the duration of the file.The patient remains ongoing on heartmate (hm) ii left ventricular assist system (lvas), serial number (b)(6).No further related events have been reported at this time.The heartmate ii lvas instructions for use (ifu) lists device thrombosis as an adverse event which may be associated with the use of heartmate ii lvas and provides information regarding the recommended anticoagulation therapy, as well as suggested anticoagulation modifications.This document also outlines indications of pump thrombosis as well as how to respond to such events.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate (hm) ii left ventricular assist system (lvas) instructions for use (ifu)and the heartmate ii patient handbook are currently available.Section 1 of the ifu, ¿introduction¿, lists potential adverse events, including device thrombosis, that may be associated with the use of the heartmate ii lvas.Section 6 of the ifu "patient care and management" outlines the recommended anticoagulation therapy and international normalized ratio (inr) range.This section also outlines indications of pump thrombosis, as well as how to respond to such events.No further information was provided.The manufacturer is closing the file on this event.
|
| |
|
Event or Problem Description
|
|
An echocardiogram was performed but thrombus was not confirmed.The patient had no symptoms related to thrombus.The patient was given heparin and tissue plasminogen activator drops.There was no plan of care.
|
| |
|
Search Alerts/Recalls
|